Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)

Inclusion Criteria: * Adults in the following risk groups: physicians, nurses, respiratory therapists, microbiology laboratory personnel working at UCSF Benioff Children's Hospital Oakland or the University of Massachusetts Medical School as well as medical students attending accredited U.S. medical schools * Able to comprehend and follow all required study procedures * In good health as determined by a brief medical history * For females of child bearing age a negative urine pregnancy test will be required Exclusion Criteria: * Are not in the risk groups summarized above * Have not given or are unable to give written informed consent to participate in the study * Females of child bearing potential who are pregnant, or planning on becoming pregnant during the study period. * Persons with a past history of having Guillain-Barré Syndrome (GBS), or a family history of GBS in a parent or sibling. * Persons with presence or suspected presence of serious chronic disease including but not limited to: chronic cardiac disease, autoimmune disease, diabetes, hepatitis B/C, HIV, progressive neurological disease or seizure, leukemia, lymphomas, or neoplasm. * Have participated in any other investigational drug or received any other vaccine within the last 30 days. * Received a dose of a meningococcal serogroups A, C, Y, W conjugate vaccine within the previous 30 days or wish to receive a dose of this vaccine during the six month study period. * Have a history of anaphylactic shock, ast…